Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Voyageur Pharmaceuticals Statistics

Total Valuation

TSXV:VM has a market cap or net worth of CAD 30.36 million. The enterprise value is 29.45 million.

Market Cap	30.36M
Enterprise Value	29.45M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

TSXV:VM has 178.59 million shares outstanding. The number of shares has increased by 14.68% in one year.

Current Share Class	178.59M
Shares Outstanding	178.59M
Shares Change (YoY)	+14.68%
Shares Change (QoQ)	+3.90%
Owned by Insiders (%)	9.07%
Owned by Institutions (%)	n/a
Float	162.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,749.98
PB Ratio	21.04
P/TBV Ratio	21.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.42
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.89

Financial Position

The company has a current ratio of 0.58, with a Debt / Equity ratio of 0.03.

Current Ratio	0.58
Quick Ratio	0.49
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -261.78% and return on invested capital (ROIC) is -127.04%.

Return on Equity (ROE)	-261.78%
Return on Assets (ROA)	-52.14%
Return on Invested Capital (ROIC)	-127.04%
Return on Capital Employed (ROCE)	-167.56%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	0.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.91% in the last 52 weeks. The beta is 0.90, so TSXV:VM's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	+61.91%
50-Day Moving Average	0.15
200-Day Moving Average	0.18
Relative Strength Index (RSI)	54.97
Average Volume (20 Days)	142,762

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:VM had revenue of CAD 11,040 and -3.13 million in losses. Loss per share was -0.02.

Revenue	11,040
Gross Profit	-2,830
Operating Income	-2.51M
Pretax Income	-3.13M
Net Income	-3.13M
EBITDA	-2.51M
EBIT	-2.51M
Loss Per Share	-0.02

Balance Sheet

The company has 946,655 in cash and 40,000 in debt, giving a net cash position of 906,655 or 0.01 per share.

Cash & Cash Equivalents	946,655
Total Debt	40,000
Net Cash	906,655
Net Cash Per Share	0.01
Equity (Book Value)	1.44M
Book Value Per Share	0.01
Working Capital	-920,123

Cash Flow

In the last 12 months, operating cash flow was -2.49 million and capital expenditures -213,319, giving a free cash flow of -2.71 million.

Operating Cash Flow	-2.49M
Capital Expenditures	-213,319
Free Cash Flow	-2.71M
FCF Per Share	-0.02

Margins

Gross Margin	-25.63%
Operating Margin	-22,717.04%
Pretax Margin	-28,307.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:VM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.68%
Shareholder Yield	-14.68%
Earnings Yield	-10.29%
FCF Yield	-8.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSXV:VM has an Altman Z-Score of -1.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.54
Piotroski F-Score	2